Ftse Mib
33.009,56
-0,66%
DAX
18.980,49
-0,11%
S&P 500
5.917,11
0,00%
NASDAQ
18.966,14
-0,11%
Bitcoin
97.641,40
3,48%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Fortress Biotech Inc (FBIO) Fortress Biotech Inc (FBIO) Notizie

Fortress Biotech Inc

FBIO
1,57
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 11:20:48
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/11/202422:10GLOBEFortress Biotech Reports Third Quarter 2024 Financial..
14/11/202422:05GLOBEAvenue Therapeutics Reports Third Quarter 2024 Financial..
12/11/202422:01GLOBEJourney Medical Corporation Reports Third Quarter 2024..
12/11/202414:30GLOBEMustang Bio Receives Positive Listing Determination from..
07/11/202414:30GLOBEMustang Bio Granted Orphan Drug Designation by U.S. FDA for..
04/11/202413:00GLOBEJourney Medical Corporation Announces U.S. FDA Approval of..
25/10/202414:30GLOBEJourney Medical Corporation Announces DFD-29 Data Presented..
24/10/202420:10GLOBEMustang Bio Announces Exercise of Warrants for $4 Million..
09/10/202414:30GLOBEAvenue Therapeutics to Participate in Maxim Group’s 2024..
03/10/202414:30GLOBEJourney Medical Corporation to Participate in the 3rd Annual..
26/9/202414:30GLOBEFortress Biotech to Participate in October 2024 Investor..
20/9/202414:30GLOBEFortress Biotech Announces Pricing of $8 Million Registered..
09/9/202414:30GLOBEJourney Medical Corporation to Participate in the Lake..
04/9/202414:30GLOBEFortress Biotech to Present at the H.C. Wainwright 26th..
04/9/202414:15GLOBEJourney Medical Corporation to Present at the H.C...
03/9/202414:30GLOBEAvenue Therapeutics to Participate in Upcoming Investor..
13/8/202422:05GLOBEFortress Biotech Reports Second Quarter 2024 Financial..
12/8/202422:01GLOBEJourney Medical Corporation Reports Second Quarter 2024..
09/8/202422:05GLOBEAvenue Therapeutics Reports Second Quarter 2024 Financial..
06/8/202422:01GLOBEJourney Medical Corporation to Announce Second Quarter 2024..
25/7/202414:30GLOBEFortress Biotech Reduces Total Debt and Enters into New $35..
11/7/202422:05GLOBEJourney Medical Corporation Appoints Michael C. Pearce to..
05/7/202422:05GLOBEFortress Biotech Announces Pause in Payment of Dividends on..
21/6/202422:01GLOBEMustang Bio Announces Closing of $2.5 Million Registered..
20/6/202414:30GLOBEAvenue Therapeutics to Present at the H.C. Wainwright 5th..
20/6/202414:00GLOBEMustang Bio Announces $2.5 Million Registered Direct..
17/6/202414:30GLOBEMustang Bio Announces Favorable Efficacy and Safety Data..
16/5/202414:30GLOBEAvenue Therapeutics Announces Last Patient Last Visit in..
16/5/202414:00GLOBEFortress Biotech to Participate in the Alliance Global..
15/5/202422:15GLOBEFortress Biotech Reports First Quarter 2024 Financial..
15/5/202422:01GLOBEJourney Medical Corporation to Participate in the Alliance..
15/5/202414:30GLOBEAvenue Therapeutics Reports First Quarter 2024 Financial..
14/5/202414:30GLOBEFortress Biotech Announces First Patient Dosed in..
13/5/202422:01GLOBEJourney Medical Corporation Reports First Quarter 2024..
07/5/202414:30GLOBEJourney Medical Corporation to Announce First Quarter 2024..
02/5/202422:01GLOBEMustang Bio Announces Closing of $4 Million Public Offering
01/5/202422:01GLOBEJourney Medical Corporation Appoints Joseph Benesch as Chief..
30/4/202402:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
29/4/202414:00GLOBEAvenue Therapeutics Announces Exercise of Warrants for $4.4..
25/4/202414:30GLOBEJourney Medical Corporation to Present at the Planet..
24/4/202413:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
28/3/202421:05GLOBEFortress Biotech Reports 2023 Financial Results and Recent..
28/3/202414:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
25/3/202413:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
21/3/202421:01GLOBEJourney Medical Corporation Reports Full-Year 2023 Financial..
18/3/202421:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
18/3/202413:30GLOBEJourney Medical Corporation Announces U.S. FDA Acceptance of..
15/3/202413:30GLOBEJourney Medical Corporation to Announce Year End 2023..
15/3/202413:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
13/3/202413:30GLOBEJourney Medical Corporation to Participate in the 36th..
Apertura: Min: Max:
Chiusura: 1,57

La tua Cronologia

NASDAQ
FBIO
Fortress Biotech
EU
MLFTI
France Tourisme Immobilier
BIT
CAI
Cairo Communication
BOV
VALEK575W4
VALEK575W4 Ex:57,5
NYSE
RACE
Ferrari NV
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network